13 бет - Ең жақсы Биопсия дәрігерлері - ЖОҒ-423 дәрігерлер

Дәрігер урология саласында үлкен тәжірибесі бар көрнекті онкохирург. Озық хирургиялық әдістерге маманданған дәрігер урологиялық онкология саласына елеулі үлес қосты. Минималды инвазивті процедураларға назар аудара отырып, дәрігер көптеген күрделі операцияларды сәтті орындап, пациенттердің нәтижелерін жақсартты. Дәрігер сондай-ақ клиникалық зерттеулерге белсенді қатысады, бірнеше рецензияланған жарияланымдарға үлес қосып, халықаралық конференцияларда нәтижелерді ұсынады.<\/p>

Дәрігер әртүрлі қатерлі ісіктерді емдеуде кең тәжірибесі бар жоғары білікті радиотерапия маманы және онколог болып табылады. Алдыңғы қатарлы радиотерапия әдістеріне маманданған дәрігер инновациялық емдеу жоспарлары арқылы пациенттердің нәтижелерін жақсартуға айтарлықтай үлес қосты. Дәрігер жетекші медициналық кеңестермен аккредиттелген және беделді медициналық журналдарда көптеген ғылыми мақалалар жариялап, онкология саласын жаңашыл жаңалықтармен байытты.<\/p>

Дәрігер қатерлі ісікті емдеуге арналған озық хирургиялық әдістерге маманданған тәжірибелі онкохирург. Бұл салада кең ауқымды тәжірибесі бар дәрігер пациенттердің нәтижелерін жақсартуға бағытталған инновациялық хирургиялық протоколдардың дамуына елеулі үлес қосты. Дәрігер клиникалық жетілдіруге деген адалдығы үшін танылып, беделді медициналық журналдарда көптеген зерттеу мақалаларын жариялады. Профессор ретінде дәрігер келесі буын хирургтарды оқытуға белсенді қатысып, онкохирургияда дәлдік пен пациентке бағытталған күтімнің маңыздылығын атап көрсетеді.<\/p>

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Professor Dr. Kurt Rasche is a German pulmonologist with more than 40 years of clinical experience. He is Chief of Pulmonology at Helios University Hospital Wuppertal. He leads the departments of pulmonology, sleep medicine, and ventilation therapy. He also heads the certified Lung Cancer Center.

He is certified in internal medicine, pulmonology, allergology, sleep medicine, and intensive care. His clinical work focuses on diagnosing and treating chronic lung diseases, lung cancer, and sleep-related breathing disorders. He works closely with specialists from other fields to provide coordinated care.

Дәрігер сүт безі хирургиясына маманданған жоғары тәжірибелі маммолог. Инновациялық хирургиялық әдістерге назар аудара отырып, дәрігер сүт безі хирургиясы бөлімін басқарады, пациенттерге жоғары деңгейде күтім мен нәтижелерді қамтамасыз етеді. Дәрігер сүт безі қатерлі ісігін емдеуге қосқан үлесі үшін танылып, беделді медициналық журналдарда көптеген зерттеу мақалаларын жариялады. Дәрігер сонымен қатар сүт безі қатерлі ісігін емдеуді жақсартуға бағытталған клиникалық сынақтарға қатысады және хирургиялық тәжірибе мен пациенттерге күтім көрсетудегі жетістіктері үшін бірнеше марапаттарға ие болды.<\/p>

Dr. Do‑young Jeong is an obstetrician‑gynecologist focused on minimally invasive, single‑port, and robotic surgery. Dr. Jeong completed an internship at Seoul National University Hospital. Dr. Jeong completed residency and graduate training at Korea University. Dr. Jeong then completed a fellowship in gynecologic oncology at the National Cancer Center, focusing on uterine and ovarian disease. Dr. Jeong served as director and chief medical officer at MizMedi Hospital and Incheon Sejong Hospital. Dr. Jeong later served as vice president at Dongtan Jeil Hospital. Dr. Jeong is a Clinical Professor at Kyung Hee University Hospital at Gangdong and an Adjunct Professor at Korea University. Dr. Jeong also serves on expert committees for KSGO, MOHW, MFDS, and KHIDI.

Professional memberships include the Korean societies for obstetrics and gynecology, gynecologic endoscopy, gynecologic robotic surgery, and reproductive medicine, as well as ISUOG. Dr. Jeong holds patents for single‑port surgical devices, including a camera, access ring, and irrigation system. Honors include the Korea University Outstanding Resident Award and the KSGE Best Poster Award. Dr. Jeong was first author of SCI‑indexed papers in 2013 and 2014. From 2023 to 2025, Dr. Jeong led studies on da Vinci SP myomectomy and hysterectomy, and on HIFU.

Дәрігер эндоскопиялық және лапароскопиялық операцияларға маманданған гинеколог. Аз инвазивті хирургиялық әдістерге назар аудара отырып, дәрігер пациенттердің қалпына келуі мен нәтижелерін жақсартатын озық процедураларды орындауда шебер. Дәрігер күрделі гинекологиялық жағдайларды басқаруда үлкен тәжірибеге ие, оңтайлы күтімді қамтамасыз ету үшін заманауи технологияларды пайдаланады.<\/p>

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Asist. Prof. Dr. Paul Stanciu is a Consultant Gynaecological Surgeon and subspecialist in Gynaecological Oncology and Robotic Surgery. He has worked in Germany, Ireland, and the UK, including at The Royal Marsden Hospital.

He is the first gynaecologist worldwide accredited by SERGS to operate on two robotic platforms. He is among the few who perform complex minimally invasive procedures, including surgery for endometriosis and fertility-sparing surgery for young cancer patients.

His expertise includes the surgical treatment of benign and malignant gynaecological conditions. He is experienced in advanced laparoscopic surgery and uses innovative techniques published internationally.

Dr. Stanciu is the author or co-author of many scientific articles. He has delivered over 100 presentations at national and international conferences. He holds certifications from SERGS, ESGO, BSCCP, and IOTA, and is an active member of major professional societies.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Дәрігер акушерлік және гинекология саласында, ана мен ұрық медицинасы және минималды инвазивті хирургиялық техникаларға маманданған. 20 жылдан астам тәжірибесі бар дәрігер пренатальды күтім бойынша бірнеше жаңашыл зерттеулерге үлес қосып, көптеген рецензияланған журналдарда жарияланған. Дәрігер сертификатталған акушер-гинеколог болып табылады және пациенттерге көрсеткен қызметі үшін көптеген марапаттарға ие болған.<\/p>

Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.

Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.

Prof. Thomas W Kraus is a renowned gastrointestinal doctor in Germany with over 30 years of experience and 3,000+ surgical interventions performed. He specializes in Whipple procedure management, stomach oncology and treatment of liver diseases, and is the Chief Physician in Nordwest Clinic in Francfurt am Main. Prof. Kraus is a member of several prestigious national and international medical associations, and has received numerous awards for his achievements. He has a wide range of surgical services, including laparotomy, laparoscopy, radical resection, draining of inflammatory diseases, bile ducts surgical reconstruction, bypass, stapling of the damaged bile ducts, endoscopic correction of hernias, and more.